ZEPP Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$43.86median target· current $2.20 (+1893.6%)1 analyst
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
49 articles · sorted by datePage 1 of 3 · 49 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 3.12
EPS (TTM)$-6.08-68.1% YoY
Profit margin-15.8%TECHNOLOGY
Market cap$32.3MMicro cap
Valuation
- Forward P/E
- 3.12
- PEG ratio
- —
- P/B
- 0.18
- P/S (TTM)
- 0.12
- EV/EBITDA
- -0.50
Profitability & growth
- ROE (TTM)
- -21.2%
- Operating margin
- -19.4%
- Revenue growth YoY
- 6.9%
- Dividend yield
- —
- Beta
- 1.81
Last earnings
Sep 1, 2026 · Reported $-0.84
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Zepp Health Corp
Company profileZepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Classification
- Sector
- Technology
- Industry
- Consumer Electronics
- Exchange
- NYSE
- Country
- China
- Currency
- USD
Company profile
- HQ
- EDISONWEG 44 ? B08, GORINCHEM, NETHERLANDS
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$32.3M
Shares outstanding$8.5M
52W high$42.35
52W low$2.15
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent